Short communicationActivity of pradimicin BMS-181184 against Aspergillus spp

Add time:08/29/2019    Source:sciencedirect.com

The pradimicins are a new class of antifungal agents with activity against the majority of human fungal pathogens. In this study, the in vitro activity of pradimicin BMS-181184 was investigated against a range of the most common species of Aspergillus. The results were compared with itraconazole and amphotericin B. BMS-181184 was found to be active against most Aspergillus spp., but at higher concentrations than itraconazole and amphotericin B.

We also recommend Trading Suppliers and Manufacturers of Pradimicin M (cas 132971-63-2). Pls Click Website Link as below: cas 132971-63-2 suppliers

Prev:Chapter 14 Stereoselective synthesis of polyunsaturated γ-alkylidenebutenolides: The total synthesis of the Xerulin (cas 132971-61-0)s
Next:Interaction of three pradimicin derivatives with divalent cations in aqueous solution)